Patents Assigned to Pathobiotek Diagnostics Inc.
  • Publication number: 20020155519
    Abstract: The present invention reports a newly-identified human blood bacterium (HBB), provides characterization, culturing and diagnostic methodologies therefor and methods for the treatment of pathophysiological states caused by the bacterium. The bacterium is apparently present in the bloodstream of all humans in very low numbers, and appears to be directly or indirectly associated with several diseases such as chronic fatigue syndrome, multiple sclerosis and other “autoimmune” diseases. Also provided are uses of engineered HBB.
    Type: Application
    Filed: June 28, 2001
    Publication date: October 24, 2002
    Applicant: Pathobiotek Diagnostics Inc.
    Inventors: Luther E. Lindner, Kathleen MacPhee
  • Patent number: 6255467
    Abstract: The present invention reports a newly-identified human blood bacterium (HBB), provides characterization, culturing and diagnostic methodologies therefor and methods for the treatment of pathophysiological states caused by the bacterium. The bacterium is apparently present in the bloodstream of all humans in very low numbers, and appears to be directly or indirectly associated with several diseases such as chronic fatigue syndrome, multiple sclerosis and other “autoimmune” diseases. Also provided are uses of engineered HBB.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: July 3, 2001
    Assignee: Pathobiotek Diagnostics Inc.
    Inventors: Luther E. Lindner, Kathleen MacPhee